Table 2 Base-case probabilities and sensitivity analysis parameter estimates

From: Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer

Parameters

High risk [sensitivity estimates]

Moderate risk [sensitivity estimates]

Mutation prevalence

18% (Stoppa-Lyonnet et al, 1997) [7% (Couch et al, 1997; Stoppa-Lyonnet et al, 1997), 27% (Eccles et al, 1998)]

 

Mutation penetrance

BRCA1/2

25%a [17%, 33%]c

 

82% (Easton et al, 1993) [70%a, 82%]

 
 

Unidentified mutation

 
 

40%a [35%, 40%]a

 

Prophylactic mastectomy

5%c [5%c, 38%d]

0%c

Prophylactic oophorectomy

5%c [0%c, 14%d]

0%c

Prophylactic mastectomy and oophorectomy

5%c [0%c, 13%d]

0%c

5 year death rate for genetics service patients

35 – 54 years 7.8% – 2 year lead time [3.8% with no lead time, 9.4% with a 2 year lead time]b

3554 years 7.8% – 2 year lead time [3.8% with no lead time, 9.4% with a 2 year lead time]b

 

55 – 59 years 11.5% – 2 year lead time [6.9% with no lead time, 16.7% with a 2 year lead time]b

55 – 59 years 11.5%-2 year lead time [6.9% with no lead time, 16.7% with a 2 year lead time]b

5 year death rate for nongenetics service patients

35 – 54 years 28.4%b [24.4%, 35.1%) – no lead timeb

35–54 years 28.4%b [24.4%, 35.1%] – no lead timeb

 

55 – 59 years 34.9% [30.2%, 39.0%] – no lead timeb

55 – 59 years 34.9% [30.2%, 39.0%] – no lead timeb

Number of Markov cycles/years

24 [15, 24]

19 [9, 19]

  1. aPDP Pharoah (personal communication, 2002).
  2. bH Beer and H Fielder, Breast Test Wales (personal communication, 2002).
  3. cEstimated by this research team.
  4. dUp to 35 – 51% of women at increased risk of developing breast cancer (Hatcher et al, 2001; Meijers-Heijboer et al, 2003) have been found to have prophylactic mastectomy and 27 – 49% (Meijers-Heijboer et al, 2003; Schwartz et al, 2003) of women at increased risk of developing ovarian cancer have opted to have prophylactic oophorectomy. As this model deals solely with women with a family history of breast cancer, we estimated that a maximum of 51% of women will have mastectomy (38% mastectomy alone +13% mastectomy and oophorectomy) and 27% will have oophorectomy (14% oophorectomy alone +13% mastectomy and oophorectomy).